表紙
市場調查報告書

米蛋白質為基礎的幼兒相關調整食品的全球市場 - 產業趨勢與預測

Global Rice Protein Based Infant Formula Market: Industry Trends and Forecast to 2026

出版商 Data Bridge Market Research Private Limited 商品編碼 904426
出版日期 內容資訊 英文 305 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
米蛋白質為基礎的幼兒相關調整食品的全球市場 - 產業趨勢與預測 Global Rice Protein Based Infant Formula Market: Industry Trends and Forecast to 2026
出版日期: 2019年07月01日內容資訊: 英文 305 Pages
簡介

本報告提供全球米蛋白質為基礎的幼兒相關調整食品市場變化考察,各領域,地區趨勢和企業競爭的現狀相關之調查資訊。

第1章 簡介

  • 調查的目的
  • 市場定義
  • 米蛋白質為基礎的幼兒相關調整食品的全球市場概要
  • 貨幣換算和價格
  • 規定
  • 調查對象市場

第2章 市場區隔

  • 調查對象市場
  • 米蛋白質為基礎的幼兒相關調整食品的全球市場 - 地理範圍
  • 調查預測對象年度
  • 貨幣換算和價格
  • Data Bridge Market Research(以下DBMR)三角法資料檢驗模式
  • 對主要意見領袖的直接取材
  • DBMR的市場排行榜
  • DBMR的經營者佔有率分析
  • 多變數建模
  • 技術壽命曲線
  • 多變數建模
  • 產品壽命曲線
  • 二級資訊來源
  • 前提

第3章 市場概要

  • 推動要素
  • 阻礙因素
  • 發展機會
  • 課題

第4章 摘要整理

第5章 應特別記載考察點

第6章 米蛋白質為基礎的幼兒相關調整食品的全球市場 - 各種類

  • 概要
  • 斷奶食品
  • 嬰幼兒調整食品
  • 標準調整食品
  • 特殊調整食品

第7章 米蛋白質為基礎的幼兒相關調整食品的全球市場 - 各產品種類

  • 概要
  • 非調整食品
  • 調整食品
    • 蔬菜
    • 果實
    • 穀類

第8章 米蛋白質為基礎的幼兒相關調整食品的全球市場 - 各形式

  • 概要
  • 非基因改造食品
  • 基因改造食品

第9章 米蛋白質為基礎的幼兒相關調整食品的全球市場 - 各對象年齡層

  • 概要
  • 6∼12個月
  • 1∼3歲
  • 0∼6個月

第10章 米蛋白質為基礎的幼兒相關調整食品的全球市場 - 各銷路

  • 概要
  • 商店銷售型零售業
    • 便利商店
    • 超級市場/大型量販店
    • 專賣店
    • 日用品、食品店
    • 批發商
  • 非店面零售型零售業
    • 線上
    • 自動販賣機

第11章 米蛋白質為基礎的幼兒相關調整食品的全球市場 - 各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 荷蘭
    • 波蘭
    • 瑞典
    • 瑞士
    • 比利時
    • 丹麥
    • 俄羅斯
    • 土耳其
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 馬來西亞
    • 新加坡
    • 紐西蘭
    • 菲律賓
    • 越南
    • 其他亞太地區
  • 南美
    • 巴西
    • 阿根廷
    • 其他南美
  • 中東、非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特
    • 阿曼
    • 卡達
    • 其他中東、非洲

第12章 SWOT分析/DBMR分析

  • SWOT分析
  • DBMR分析

第13章 米蛋白質為基礎的幼兒相關調整食品的全球市場 - 企業競爭

  • 各企業市場佔有率分析 - 世界
  • 各企業市場佔有率分析 - 北美
  • 各企業市場佔有率分析 - 歐洲
  • 各企業市場佔有率分析 - 亞太地區
  • 各企業市場佔有率分析 - 中東、非洲

第14章 企業簡介(企業簡述,市場佔有率分析,產品結構,最新展開等)

  • LACTALIS INTERNATIONAL
  • NOVALAC
  • BAYER AG
  • LABORATORIOS ORDESA
  • BIOLAB PHARMA
  • KATE FARMS
  • LA MANDORLE
  • NUCITEC SA DE CV

第15章 調查問卷

第16章 結論

第17章 參考資料

第18章 相關報告

目錄

Global rice protein based infant formula market is projected to register a substantial CAGR of 5.9% in the forecast period of 2019 to 2026. The new market report contains data for thehistoric year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026

Market Segmentation

By Type (Formulated, Unformulated), Product Type (Standard Formula, Toddler Formula, Follow-On Formula, Special Formula), Form (Non-GMO, GMO), Infant Age (6-12 Months, 0-6 Months, 1-3 Years), Distribution Channel (Store-Based Retailer, Non-Store Retailer), Geography (Asia-Pacific, Europe, North America, South America, Middle East & Africa)

Some of the major factors contributing to the growth of the global rice protein based infant formula market:

  • Increasing number of birth rate
  • Rising number of children who are allergic to cow milk

Market Players:

The key market players for global rice protein based infant formula market are listed below:

  • Nucitec SA de CV
  • La Mandorle
  • Laboratorios Ordesa
  • Kate Farms
  • Bayer AG
  • Lactalis International
  • BIOLAB PHARMA
  • Novalac

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATIONS
  • 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.7 DBMR MARKET POSITION GRID
  • 2.8 DBMR VENDOR SHARE ANALYSIS
  • 2.9 MULTIVARIATE MODELING
  • 2.10 PRODUCTS LIFELINE CURVE
  • 2.11 SECONDARY SOURCES
  • 2.12 ASSUMPTIONS

3 MARKET OVERVIEW

  • 3.1 DRIVERS
    • 3.1.1 RISING POPULATION OF WORKING MOTHERS
    • 3.1.2 GROWING INFANT POPULATION
    • 3.1.3 INCREASING CASES OF BREAST CANCER
    • 3.1.4 RICE PROTEIN BASED INFANT FORMULA IS WIDELY ACCEPTED AS NON-ALLERGIC PRODUCT
  • 3.2 RESTRAINT
    • 3.2.1 STRINGENT REGULATION
  • 3.3 OPPORTUNITIES
    • 3.3.1 GROWING ECONOMIES AND DISPOSABLE INCOME IN EMERGING REGIONS
    • 3.3.2 INCREASING AWARENESS REGARDING IMPORTANCE OF NUTRITION FOR INFANTS
  • 3.4 CHALLENGES
    • 3.4.1 HIGH CONTENT OF TOXIC CHEMICALS IN RICE PROTEIN BASED INFANT FORMULA
    • 3.4.2 IMPROPER PACKAGING OF BABY FOOD

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET, BY PRODUCT TYPE

  • 6.1 OVERVIEW
  • 6.2 FOLLOW-ON FORMULA
  • 6.3 TODDLER FORMULA
  • 6.4 STANDARD FORMULA
  • 6.5 SPECIAL FORMULA

7 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET, BY TYPE

  • 7.1 OVERVIEW
  • 7.2 UNFORMULATED
  • 7.3 FORMULATED
    • 7.3.1 VEGETABLES
    • 7.3.2 FRUITS
    • 7.3.3 CEREAL

8 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET, BY FORM

  • 8.1 OVERVIEW
  • 8.2 NON-GMO
  • 8.3 GMO

9 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET, BY INFANT AGE

  • 9.1 OVERVIEW
  • 9.2 6-12 MONTHS
  • 9.3 1-3 YEARS
  • 9.4 0-6 MONTHS

10 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET, BY DISTRIBUTION CHANNEL

  • 10.1 OVERVIEW
  • 10.2 STORE-BASED RETAILER
    • 10.2.1 CONVENIENCE STORES
    • 10.2.2 SUPERMARKETS/HYPERMARKETS
    • 10.2.3 SPECIALTY STORES
    • 10.2.4 GROCERY STORES
    • 10.2.5 WHOLESALERS
  • 10.3 NON-STORE RETAILER
    • 10.3.1 ONLINE
    • 10.3.2 VENDING

11 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET, BY GEOGRAPHY

  • 11.1 OVERVIEW
  • 11.2 NORTH AMERICA
    • 11.2.1 U.S.
    • 11.2.2 CANADA
    • 11.2.3 MEXICO
  • 11.3 EUROPE
    • 11.3.1 GERMANY
    • 11.3.2 FRANCE
    • 11.3.3 U.K.
    • 11.3.4 ITALY
    • 11.3.5 SPAIN
    • 11.3.6 NETHERLANDS
    • 11.3.7 POLAND
    • 11.3.8 SWEDEN
    • 11.3.9 SWITZERLAND
    • 11.3.10 BELGIUM
    • 11.3.11 DENMARK
    • 11.3.12 RUSSIA
    • 11.3.13 TURKEY
    • 11.3.14 REST OF EUROPE
  • 11.4 ASIA-PACIFIC
    • 11.4.1 CHINA
    • 11.4.2 JAPAN
    • 11.4.3 INDIA
    • 11.4.4 SOUTH KOREA
    • 11.4.5 AUSTRALIA
    • 11.4.6 SINGAPORE
    • 11.4.7 THAILAND
    • 11.4.8 INDONESIA
    • 11.4.9 MALAYSIA
    • 11.4.10 NEW ZEALAND
    • 11.4.11 PHILIPPINES
    • 11.4.12 VIETNAM
    • 11.4.13 REST OF ASIA-PACIFIC
  • 11.5 SOUTH AMERICA
    • 11.5.1 BRAZIL
    • 11.5.2 ARGENTINA
    • 11.5.3 REST OF SOUTH AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 SOUTH AFRICA
    • 11.6.2 SAUDI ARABIA
    • 11.6.3 UAE
    • 11.6.4 KUWAIT
    • 11.6.5 OMAN
    • 11.6.6 QATAR
    • 11.6.7 REST OF MIDDLE EAST & AFRICA

12 SWOT & DBMR ANALYSIS

  • 12.1 SWOT ANALYSIS
  • 12.2 DATA BRIDGE MARKET RESEARCH ANALYSIS

13 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET, COMPANY LANDSCAPE

  • 13.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 13.3 COMPANY SHARE ANALYSIS: EUROPE
  • 13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
  • 13.5 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

14 COMPANY PROFILE

  • 14.1 LACTALIS INTERNATIONAL
    • 14.1.1 COMPANY SNAPSHOT
    • 14.1.2 COMPANY SHARE ANALYSIS
    • 14.1.3 PRODUCT PORTFOLIO
    • 14.1.4 RECENT DEVELOPMENTS
  • 14.2 NOVALAC
    • 14.2.1 COMPANY SNAPSHOT
    • 14.2.2 COMPANY SHARE ANALYSIS
    • 14.2.3 PRODUCT PORTFOLIO
    • 14.2.4 RECENT DEVELOPMENT
  • 14.3 BAYER AG
    • 14.3.1 COMPANY SNAPSHOT
    • 14.3.2 REVENUE ANALYSIS
    • 14.3.3 COMPANY SHARE ANALYSIS
    • 14.3.4 PRODUCT PORTFOLIO
    • 14.3.5 RECENT DEVELOPMENT
  • 14.4 LABORATORIOS ORDESA
    • 14.4.1 COMPANY SNAPSHOT
    • 14.4.2 COMPANY SHARE ANALYSIS
    • 14.4.3 PRODUCT PORTFOLIO
    • 14.4.4 RECENT DEVELOPMENT
  • 14.5 BIOLAB PHARMA
    • 14.5.1 COMPANY SNAPSHOT
    • 14.5.2 PRODUCT PORTFOLIO
    • 14.5.3 RECENT DEVELOPMENT
  • 14.6 KATE FARMS
    • 14.6.1 COMPANY SNAPSHOT
    • 14.6.2 PRODUCT PORTFOLIO
    • 14.6.3 RECENT DEVELOPMENT
  • 14.7 LA MANDORLE
    • 14.7.1 COMPANY SNAPSHOT
    • 14.7.2 PRODUCT PORTFOLIO
    • 14.7.3 RECENT DEVELOPMENT
  • 14.8 NUCITEC SA DE CV
    • 14.8.1 COMPANY SNAPSHOT
    • 14.8.2 PRODUCT PORTFOLIO
    • 14.8.3 RECENT DEVELOPMENT

15 QUESTIONNAIRE

16 CONCLUSION

17 RELATED REPORTS

LIST OF FIGURES

  • FIGURE 1 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: SEGMENTATION
  • FIGURE 2 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: DATA VALIDATION MODEL
  • FIGURE 3 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: DROC ANALYSIS
  • FIGURE 4 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: DBMR VENDOR SHARE ANALYSIS
  • FIGURE 9 DRIVERS, RESTRAINT, OPPORTUNITIES AND CHALLENGES OF GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET
  • FIGURE 10 PERCENTAGE OF WORKING MOTHERS HAVING YOUNGEST CHILD OF 3 OR 4 YEARS OLD (2010 -2017)
  • FIGURE 11 ESTIMATED NUMBER OF INCIDENT CASES OF BREAST CANCER IN FEMALES, 2018
  • FIGURE 12 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: SEGMENTATION
  • FIGURE 13 ASIA-PACIFIC IS ANTICIPATED TO DOMINATE THE RICE PROTEIN BASED INFANT FORMULA MARKET AND IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 14 GROWING INFANT POPULATION AND RISING POPULATION OF WORKING MOTHERS ARE EXPECTED TO DRIVE THE GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 15 FOLLOW-ON FORMULA IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET IN 2019 & 2026
  • FIGURE 16 ASIA-PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 17 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: BY PRODUCT TYPE, 2018
  • FIGURE 18 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: BY TYPE, 2018
  • FIGURE 19 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: BY FORM, 2018
  • FIGURE 20 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: BY INFANT AGE, 2018
  • FIGURE 21 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: SNAPSHOT (2018)
  • FIGURE 22 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: BY GEOGRAPHY (2018)
  • FIGURE 23 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: BY GEOGRAPHY (2019 & 2026)
  • FIGURE 24 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: BY GEOGRAPHY (2018 & 2026)
  • FIGURE 25 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: BY PRODUCT TYPE (2019-2026)
  • FIGURE 26 NORTH AMERICA RICE PROTEIN BASED INFANT FORMULA MARKET: SNAPSHOT (2018)
  • FIGURE 27 NORTH AMERICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2018)
  • FIGURE 28 NORTH AMERICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 29 NORTH AMERICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 30 NORTH AMERICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY PRODUCT TYPE (2019-2026)
  • FIGURE 31 EUROPE RICE PROTEIN BASED INFANT FORMULA MARKET: SNAPSHOT (2018)
  • FIGURE 32 EUROPE RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2018)
  • FIGURE 33 EUROPE RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 34 EUROPE RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 35 EUROPE RICE PROTEIN BASED INFANT FORMULA MARKET: BY PRODUCT TYPE (2019-2026)
  • FIGURE 36 ASIA-PACIFIC RICE PROTEIN BASED INFANT FORMULA MARKET: SNAPSHOT (2018)
  • FIGURE 37 ASIA-PACIFIC RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2018)
  • FIGURE 38 ASIA-PACIFIC RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 39 ASIA-PACIFIC RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 40 ASIA-PACIFIC RICE PROTEIN BASED INFANT FORMULA MARKET: BY PRODUCT TYPE (2019-2026)
  • FIGURE 41 SOUTH AMERICA RICE PROTEIN BASED INFANT FORMULA MARKET: SNAPSHOT (2018)
  • FIGURE 42 SOUTH AMERICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2018)
  • FIGURE 43 SOUTH AMERICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 44 SOUTH AMERICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 45 SOUTH AMERICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY PRODUCT TYPE (2019-2026)
  • FIGURE 46 MIDDLE EAST & AFRICA RICE PROTEIN BASED INFANT FORMULA MARKET: SNAPSHOT (2018)
  • FIGURE 47 MIDDLE EAST & AFRICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2018)
  • FIGURE 48 MIDDLE EAST & AFRICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 49 MIDDLE EAST & AFRICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 50 MIDDLE EAST & AFRICA RICE PROTEIN BASED INFANT FORMULA MARKET: BY PRODUCT TYPE (2019-2026)
  • FIGURE 51 GLOBAL RICE PROTEIN BASED INFANT FORMULA MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 52 NORTH AMERICA RICE PROTEIN BASED INFANT FORMULA MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 53 EUROPE RICE PROTEIN BASED INFANT FORMULA MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 54 ASIA-PACIFIC RICE PROTEIN BASED INFANT FORMULA MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 55 MIDDLE EAST & AFRICA RICE PROTEIN BASED INFANT FORMULA MARKET: COMPANY SHARE 2018 (%)
Back to Top